Erschienen in:

10.11.2018

Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Mexidol in Prolonged Sequential Therapy of Patients in the Acute and Early Recovery Stages of Hemispheric Stroke (the EPICA study)

verfasst von: L. V. Stakhovskaya, N. A. Shamalov, D. R. Khasanova, E. V. Mel’nikova, A. S. Agaf’ina, K. V. Golikov, E. I. Bogdanov, A. A. Yakupova, L. V. Roshkovskaya, L. V. Lukinykh, T. M. Lokshtanova, I. E. Poverennova, L. A. Shchepankevich

Erschienen in: Neuroscience and Behavioral Physiology | Ausgabe 8/2018